AccessClosure

AccessClosure is a medical device company based in Santa Clara, California, founded in 2002. It specializes in developing vascular closure devices that enhance patient comfort and safety during cardiovascular and peripheral vascular procedures. As a subsidiary of Cardinal Health, AccessClosure employs around 48 people. The company's main product line is the Mynx Product Family, which includes the Mynx Ace and MynxGrip devices. These devices utilize a water-soluble sealant that expands in the tissue tract to effectively seal the arteriotomy site after catheter-based interventions. This innovative approach offers a pain-free alternative to manual pressure for vascular access closure. Additionally, AccessClosure is the exclusive distributor in the U.S. for the Flash Ostial System Dual Balloon Angioplasty Catheter, further enhancing its offerings in interventional cardiology. AccessClosure's products are primarily marketed to hospitals and catheterization laboratories, with devices available in over 1,200 catheter labs worldwide. The company has seen significant growth, achieving annual revenues exceeding $80 million by the time of its acquisition by Cardinal Health.

• Employees 46
• Founded 2002
• Annual Revenue $11877000
• Total Funding $10000000